Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …

Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a potentially dose‐limiting side
effect of several commonly used cytotoxic chemotherapy agents. The main pharmacological …

Neurological complications of cancer and of anticancer treatments can be substantially
disabling to patients, especially with classic chemotherapies. As a rare but important …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major clinical problem because
it represents the dose-limiting side-effect of a significant number of antineoplastic drugs [1] …

Background Reliable reporting of chemotherapy-induced neurotoxicity is important. The
objectives of the current study were to evaluate the differences in the peripheral …

Neurotoxicity caused by traditional chemotherapy and radiotherapy is widely recognized in
patients with cancer. The adverse effects of newer therapeutics, such as biological and …

The peripheral nervous system can be vulnerable to the toxic action of several drugs since it
is not protected as effectively as the central nervous system from noxious exogenous agents …

Chemotherapy-Induced Peripheral Neurotoxicity (CIPN) is a frequent, potentially severe and
dose-limiting side-effect of cancer treatment. Despite its clinical relevance that limits the use …

Peripheral neuropathy can be defined as a derangement in structure and function of
peripheral motor, sensory, and autonomic neurons [1], causing peripheral neuropathic …

Peripheral neuropathies induced by chemotherapy (CIPN) are an increasingly frequent
problem. Contrary to hematologic adverse effects, which can be treated with hematopoetic …